Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report
Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.30.8387
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)